These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8547072)

  • 1. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Myint H; Copplestone JA; Orchard J; Craig V; Curtis D; Prentice AG; Hamon MD; Oscier DG; Hamblin TJ
    Br J Haematol; 1995 Oct; 91(2):341-4. PubMed ID: 8547072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
    Syed NN; Khurshid M
    J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia.
    Ford CD; Asch J; Pulsipher M; Petersen FB
    Br J Haematol; 2004 Aug; 126(4):623-4. PubMed ID: 15287959
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.
    Tosti S; Caruso R; D'Adamo F; Picardi A; Ali Ege M; Girelli G; Mauro FR; Maurillo L; Amadori S
    Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
    Swords R; Nolan A; Fay M; Quinn J; O'Donnell R; Murphy PT
    Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Maclean R; Meiklejohn D; Soutar R
    Br J Haematol; 1996 Mar; 92(3):768-9. PubMed ID: 8616054
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
    Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
    Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
    Hamblin TJ; Orchard JA; Myint H; Oscier DG
    J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fludarabine and fatal hemolytic anemia].
    López L; del Villar V; Pascual T
    Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
    Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G
    Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evan's syndrome precipitated by fludarabine therapy in a case of CLL.
    Sen K; Kalaycio M
    Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320
    [No Abstract]   [Full Text] [Related]  

  • 14. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
    Leach M; Parsons RM; Reilly JT; Winfield DA
    Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
    Hocepied AM; Falkson CI; Falkson G
    S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
    Smolej L
    Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
    Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
    Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine).
    Robak T; Błasińska-Morawiec M; Krykowski E; Hellmann A; Konopka L
    Eur J Haematol; 1997 Feb; 58(2):109-13. PubMed ID: 9111592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine-induced hemolytic anemia: successful treatment by rituximab.
    Paydas S
    Hematol J; 2004; 5(1):81-3. PubMed ID: 14745435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.